Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059241) titled 'A Multicenter Prospective Registry of Systemic Therapy for Unresectable Hepatocellular Carcinoma with Linked Multi-omics Biobanking and Translational Validation' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka
Condition:
Condition - Hepatocellular Carcinoma
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To elucidate predictors of therapeutic efficacy for each pharmacologic treatment of hepatocellular carcinoma and to identify clinically useful blood-based and histopathologic biomarkers. We will prospectively register ...